IMV Inc. Announces First Quarter 2021 Financial and Operational Results and Expansion of its Clinical Pipeline
Press release content from Business Wire. The AP news staff was not involved in its creation. IMV Inc. Announces First Quarter 2021 Financial and Operational Results and Expansion of its Clinical Pipeline May 12, 2021 GMT DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--May 12, 2021-- IMV Inc. (the “Company” or “IMV”) (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced its financial and operational results for the first quarter ended March 31, 2021. “We remain focused on our commitment to provide effective and well...